Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?

OBJECTIVE: Doses of gonadotropin releasing hormone (GnRH) analogues used to treat idiopathic central precocious puberty (iCPP) vary among clinicians. Study aims were to evaluate the efficacy of a monthly 3.75 mg dose of leuprolide acetate (LA) to suppress the hypothalamo-pituitary-gonadal (HPG) axis...

Descripción completa

Detalles Bibliográficos
Autores principales: Vurallı, Doğuş, Alikaşifoğlu, Ayfer, İyigün, İrem, Canoruç, Dicle, Ozon, Alev, Gönç, Nazlı, Kandemir, Nurgün
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127887/
https://www.ncbi.nlm.nih.gov/pubmed/31347350
http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.0060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127887/
https://www.ncbi.nlm.nih.gov/pubmed/31347350
http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.0060

Ejemplares similares